• 1
    Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med 2000; 161: 8729
  • 2
    Weisberg LS, Allgren RL, Genter FC, Kurnik BR. Cause of acute tubular necrosis affects its prognosis. The Auriculin Anaritide Acute Renal Failure study group. Arch Intern Med 1997; 157: 18338
  • 3
    Barretti P, Soares VA. Acute renal failure: clinical outcome and causes of death. Ren Fail 1997; 19: 2537
  • 4
    Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17: 114350
  • 5
    Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004; 43: 64959
  • 6
    Farrell F, Lee A. The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 2004; 9 (Suppl. 5): 1830
  • 7
    Westenfelder C, Biddle DL, Baranowski RL. Human, rat and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 80820
  • 8
    Fishbane S, Ragolia L, Palaia T, Johnson B, Elzein H, Maesaka JK. Cytoprotection by darbepoietin/epoetin alpha in pig tubular and mouse mesangial cells. Kidney Int 2004; 65: 4528
  • 9
    Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 34855
  • 10
    Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 9839
  • 11
    Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia–reperfusion. J Am Soc Nephrol 2004; 15: 211524
  • 12
    Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278: F1F12
  • 13
    Kerr JF, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol 1995; 46: 127
  • 14
    Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11: 45467
  • 15
    Ganong WF. Review of Medical Physiology, 21st edn. New York: Lange Medical Books/Mc Graw-Hill, 1995: 709
  • 16
    Bagnis C, Beaufils H, Jacquiaud C et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 2001; 16: 9328
  • 17
    Johnson DW, Forman CJ, Vesey DA. Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology. 2006 [Epub ahead of print], DOI 10.1111/j.1440-1797.2006.00585.x
  • 18
    Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome C release from the mitochondria. Cell Death Differ 2006 [Epub ahead of print], 10.1038/sj.cdd.4401950